Back to search

National and Kapodistrian University of Athens

Μελέτη του γενωμικού υπόβαθρου και της επίδρασης της νέο-επικουρικής θεραπείας σε ασθενείς με επιθηλιακό καρκίνο των ωοθηκών

Abstract

dc:description

Background: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) and adjuvant chemotherapy is a therapeutic choice for women with advanced ovarian cancer. Whether NACT affects the tumour’s molecular profile has not been determined. Methods: This was a retrospective study of patients with advanced epithelial ovarian cancer treated with NACT at oncology departments affiliated with the Hellenic Cooperative Oncology Group (HeCOG). Tumor molecular profiling was performed from formalin-fixed and paraffin-embedded (FFPE) tumor pre- and post-NACT tissues. Homologous recombination deficiency (HRD), tumor infiltrating lymphocytes (TIL), tumor molecular alterations and tumor mutational burden (TMB) via next-generation sequencing analysis were assessed. Results: Overall, tumors from thirty-six patients were assessed; molecular profiling was evaluable in 20 paired tumor samples. HRD positivity exhibited no significant change between pre- and post-NACT tumors. BRCA1/2 mutational status remained constant irrespective of the treatment administration. Pre-NACT tumors tended to exhibit a lower percentage of intratumoral TILs compared to post-NACT tumors (p=0.004). Differences in the mutation profile between pre- and post-treatment tissue were observed in 33.33% (6/18) of the cases. The mean tumor cell content (TCC) (p-value: 0.0840) and the mean genomic instability score GIS (p-value: 0.0636) decreased slightly numerically after therapy. A moderate inverse relationship was observed between pre-NACT TMB and chemotherapy response score ( p-value: 0.038), indicating this correlation is statistically significant. Conclusion: The study provides insights into how NACT affects the tumor environment and mutational landscape. While BRCA1/2 and HRD status remain stable, increases in iTILs and changes in mutational profiles are observed post-treatment. This is a factor that should be considered in making subsequent therapeutic decisions. Prospective studies are needed to investigate the clinical significance of these findings

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Nikolaidi, Adamantia
  • Νικολαΐδη, Αδαμαντία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59002

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Nikolaidi, Adamantia; Νικολαΐδη, Αδαμαντία. Μελέτη του γενωμικού υπόβαθρου και της επίδρασης της νέο-επικουρικής θεραπείας σε ασθενείς με επιθηλιακό καρκίνο των ωοθηκών. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/59002